Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity

Fig. 3

Fecal SCFA levels and urinary 3-indoxyl sulfate levels of patients with IBD stratified for fecal calprotectin levels. a SCFAs in stool of IBD patients with fecal calprotectin < 50 µg/g, < 150 µg/g, > 150 µg/g and > 500 µg/; b Urinary 3-indoxyl sulfate of patients with IBD stratified for fecal calprotectin levels. The small circles in b indicate outliers. * p < 0.05, ** p < 0.01

Back to article page